Assessing the clinical impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on metastatic neuroendocrine tumors: A multicenter real-world data from Türkiye için istatistikler
Toplam ziyaret
| views | |
|---|---|
| Assessing the clinical impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on metastatic neuroendocrine tumors: A multicenter real-world data from Türkiye | 0 |
Aylık toplam ziyaret
| views | |
|---|---|
| Kasım 2024 | 0 |
| Aralık 2024 | 0 |
| Ocak 2025 | 0 |
| Şubat 2025 | 0 |
| Mart 2025 | 0 |
| Nisan 2025 | 0 |
| Mayıs 2025 | 0 |
Dosya Ziyaretleri
| views | |
|---|---|
| Assessing the Clinical Impact of Lutetium177 DOTATATE Peptide Receptor Radionuclide Therapy PRRT on Metastatic Neuroendocrine Tumors A Multicenter RealWorld Data from Trkiye-48337.pdf | 8 |
